|
Xechem International, Inc - Comparative Business Analysis Snapshot
Business Description
Xechem International, Inc. The Group's principal activity is to conduct research and development and limited production of niche generic and proprietary drugs from natural sources. The Group extracts, isolates and purifies technology to the production and manufacture of paclitaxel. The research and development of the Group is focussed primarily on antifungal, anticancer, antiviral and anti-inflammatory compounds, antiaging and memory enhancing compounds. The Group also provides technical and analytical laboratory services including the testing of chemicals, cosmetics, food, household and pharmaceutical products on a contract basis. It also offers consulting services for development and pilot-plant production of pharmaceuticals for companies on a contract basis.
Competitor Analysis
This analysis compares Xechem International, Inc with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
